- Highlighting trusted excipients, amino acids, and advanced formulation solutions that deliver precision and reliability
- Showcasing new drug-delivery concepts such as “Mini Tablets in Capsule” for improved dosing flexibility and patient compliance
Brenntag, the global market leader in chemicals and ingredient distribution, will showcase its latest pharmaceutical innovations at CPHI India 2025, taking place at the India Expo Centre, Greater Noida, Delhi NCR, from 25 – 27 November 2025. Visitors are welcome to meet the Brenntag team at Hall 6, Booth 6.O02 to explore these innovations firsthand.
Under the theme “Innovation That Powers Possibility,” Brenntag will present a range of high-performance ingredients that bring purity, reliability, and precision to modern pharmaceutical formulations. The line-up includes Titanium Dioxide, Citric Acids and Citrates, and Mineral Salts, trusted for their consistent performance and compliance with highest regulatory standards.
Brenntag will also feature its qualified amino acids portfolio, supporting both upstream cell culture and downstream formulation processes. These amino acids function as APIs, excipients, buffers, and stabilizers, supplied with comprehensive documentation to meet the highest regulatory expectations.
Visitors can further explore Brenntag’s latest “Mini Tablets in Capsule” concept, a multiparticulated drug-delivery system designed for flexible dosing and improved patient adherence.
Romain Girard, Regional President Pharma APAC, Brenntag Specialties, said, “At Brenntag, precision defines everything we do, from sourcing high-purity excipients, salts, and amino acids to enabling next-generation formulation technologies such as 3D printing. Through our Innovation and Application Centres and strong technical partnerships, we collaborate closely with customers to transform concepts into safe, effective, and sustainable pharmaceutical solutions.”
